Raymond James & Associates Sells 72 Shares of Molina Healthcare, Inc. (NYSE:MOH)

Raymond James & Associates lowered its position in Molina Healthcare, Inc. (NYSE:MOHFree Report) by 0.2% during the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 35,214 shares of the company’s stock after selling 72 shares during the period. Raymond James & Associates owned 0.06% of Molina Healthcare worth $12,723,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors have also recently modified their holdings of the company. Annis Gardner Whiting Capital Advisors LLC acquired a new stake in Molina Healthcare in the 3rd quarter valued at $30,000. Coppell Advisory Solutions Corp. bought a new stake in shares of Molina Healthcare during the fourth quarter worth about $34,000. ST Germain D J Co. Inc. bought a new stake in shares of Molina Healthcare during the second quarter worth about $33,000. VisionPoint Advisory Group LLC raised its holdings in shares of Molina Healthcare by 105.6% in the 3rd quarter. VisionPoint Advisory Group LLC now owns 111 shares of the company’s stock worth $36,000 after acquiring an additional 57 shares during the last quarter. Finally, Brown Brothers Harriman & Co. bought a new position in Molina Healthcare in the 1st quarter valued at about $40,000. Institutional investors own 98.50% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of analysts have commented on the company. Cantor Fitzgerald boosted their price objective on Molina Healthcare from $374.00 to $406.00 and gave the stock an “overweight” rating in a report on Friday, February 9th. Barclays began coverage on Molina Healthcare in a research report on Wednesday, March 6th. They issued an “equal weight” rating and a $437.00 price target for the company. Bank of America downgraded shares of Molina Healthcare from a “neutral” rating to an “underperform” rating and set a $439.00 price objective on the stock. in a report on Thursday, March 28th. Truist Financial increased their target price on shares of Molina Healthcare from $435.00 to $460.00 and gave the company a “buy” rating in a report on Tuesday, February 20th. Finally, StockNews.com lowered shares of Molina Healthcare from a “strong-buy” rating to a “buy” rating in a research report on Thursday, February 8th. One investment analyst has rated the stock with a sell rating, four have given a hold rating and five have assigned a buy rating to the company’s stock. Based on data from MarketBeat, the stock currently has a consensus rating of “Hold” and a consensus price target of $395.82.

Get Our Latest Research Report on Molina Healthcare

Molina Healthcare Stock Down 0.6 %

MOH opened at $378.62 on Thursday. The company’s 50-day moving average price is $391.71 and its two-hundred day moving average price is $368.02. The company has a quick ratio of 1.54, a current ratio of 1.54 and a debt-to-equity ratio of 0.57. Molina Healthcare, Inc. has a twelve month low of $266.35 and a twelve month high of $423.92. The stock has a market cap of $22.18 billion, a price-to-earnings ratio of 20.16, a PEG ratio of 1.13 and a beta of 0.47.

Molina Healthcare (NYSE:MOHGet Free Report) last posted its quarterly earnings data on Wednesday, February 7th. The company reported $4.38 EPS for the quarter, beating the consensus estimate of $4.31 by $0.07. Molina Healthcare had a return on equity of 32.34% and a net margin of 3.20%. The business had revenue of $9.05 billion for the quarter, compared to the consensus estimate of $8.35 billion. During the same quarter in the prior year, the business earned $4.10 earnings per share. Molina Healthcare’s revenue for the quarter was up 10.0% on a year-over-year basis. As a group, equities analysts expect that Molina Healthcare, Inc. will post 23.62 earnings per share for the current year.

Insider Transactions at Molina Healthcare

In related news, Director Richard M. Schapiro sold 1,000 shares of the business’s stock in a transaction dated Tuesday, February 20th. The stock was sold at an average price of $401.05, for a total value of $401,050.00. Following the sale, the director now directly owns 11,207 shares in the company, valued at approximately $4,494,567.35. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. In other Molina Healthcare news, Director Richard M. Schapiro sold 711 shares of the stock in a transaction on Monday, February 12th. The stock was sold at an average price of $384.06, for a total transaction of $273,066.66. Following the sale, the director now owns 12,207 shares in the company, valued at $4,688,220.42. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, Director Richard M. Schapiro sold 1,000 shares of the firm’s stock in a transaction on Tuesday, February 20th. The stock was sold at an average price of $401.05, for a total value of $401,050.00. Following the completion of the transaction, the director now directly owns 11,207 shares of the company’s stock, valued at $4,494,567.35. The disclosure for this sale can be found here. In the last 90 days, insiders sold 16,711 shares of company stock worth $6,472,517. 1.11% of the stock is owned by company insiders.

Molina Healthcare Profile

(Free Report)

Molina Healthcare, Inc provides managed healthcare services to low-income families and individuals under the Medicaid and Medicare programs and through the state insurance marketplaces. It operates in four segments: Medicaid, Medicare, Marketplace, and Other. The company served in across 19 states. The company was founded in 1980 and is headquartered in Long Beach, California.

Recommended Stories

Institutional Ownership by Quarter for Molina Healthcare (NYSE:MOH)

Receive News & Ratings for Molina Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Molina Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.